Publisher: Adis International
ISSN: 0114-9954
Source: Reactions Weekly, Vol.1, Iss.1394, 2012-01, pp. : 11-11
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Vandetanib: Reversible cerebral vasoconstriction syndrome: case report
Reactions Weekly, Vol. 1, Iss. 1393, 2012-01 ,pp. :
Dobutamine: First report of reversible cerebral vasoconstriction syndrome: case report
Reactions Weekly, Vol. 1, Iss. 1351, 2011-01 ,pp. :
Indometacin: First report of reversible cerebral vasoconstriction in an elderly patient: case report
Reactions Weekly, Vol. 1, Iss. 1354, 2011-01 ,pp. :
Bevacizumab: Reversible posterior leukoencephalopathy syndrome: case report
Reactions Weekly, Vol. 1, Iss. 1198, 2008-01 ,pp. :